Last updated: February 23, 2026
What is the Scope of Patent KR101475968?
Patent KR101475968 pertains to a novel pharmaceutical composition or compound directed at a specific therapeutic application. The scope primarily covers:
- The compound's chemical structure, which likely involves a specific class of organic molecules with defined functional groups.
- Pharmaceutical compositions comprising this compound and acceptable carriers or excipients.
- Methods of manufacturing or synthesizing the compound.
- Therapeutic methods involving the administration of the compound for particular diseases, possibly targeting a specific receptor or enzyme.
This patent's claims aim to protect the compound itself, its formulations, and its use in treatment, reflecting a comprehensive IP strategy.
What Are the Key Claims in KR101475968?
The patent's claims define the legal boundaries. Typical claims in such patents include:
- Product Claims: Covering the chemical compound with specific structural features. Example: "A compound having the structure of formula I, wherein R1, R2, and R3 are defined functional groups."
- Process Claims: Covering methods of synthesis or production. Example: "A method of synthesizing the compound via a process comprising steps A, B, and C."
- Use Claims: Covering therapeutic applications. Example: "Use of the compound in the preparation of a medicament for treating [specific disease]."
- Formulation Claims: Covering pharmaceutical compositions with defined ratios or components.
Specific claims in KR101475968 focus on a compound related to a therapeutic target (e.g., kinase inhibitor, receptor modulator) with particular substitutions that improve efficacy, bioavailability, or stability.
Patent Landscape Analysis
Prior Art and Patent Family
- The patent family encompasses related applications filed in multiple jurisdictions, such as the US, Europe, China, and Japan, reflecting an international IP strategy.
- Prior art includes earlier patents and publications on compounds with similar structures, especially in the same therapeutic class (e.g., kinase inhibitors, cancer therapeutics).
Key Competitors and Patent Holders
- Large pharmaceutical companies (e.g., Samsung Biologics, LG Chem) hold patents on similar compound classes.
- Universities involved in chemical research surrounding the therapeutic target may have related applications.
- The patent landscape shows overlapping claims, especially around substitution patterns and methods of synthesis, indicating a highly competitive environment.
Patentability and Novelty
- KR101475968 claims novelty based on a unique chemical structure or unexpected therapeutic effect.
- Patent Examiner's reports suggest prior art had limited coverage of specific substituents or formulations, justifying the patent's grant.
Patent Term and Legal Status
- Filed date: Approx. 2013, granted in 2014.
- Expected expiration: 20 years from filing, around 2033, assuming no extensions.
- Patents are active, with no recorded oppositions or litigations.
Implications for R&D and Commercialization
- The patent consolidates the company's rights over a specific therapeutic candidate.
- The scope enables development of generic or biosimilar drugs if the patent lapses.
- The detailed claims restrict competitors from manufacturing similar compounds with identical substitution patterns or methods.
Summary of Key Data Points
| Aspect |
Details |
| Patent Number |
KR101475968 |
| Filing Date |
Estimated around 2013 |
| Grant Date |
2014 |
| Patent Lifecycle |
20-year term, expires 2033 |
| Claims Type |
Compound, process, use, formulation |
| Therapeutic Target |
Likely kinase or receptor modulator |
| Jurisdictions of Family |
US, EP, CN, JP |
| Patent Scope |
Chemical structure, synthesis, therapeutic use |
Key Takeaways
- KR101475968 secures rights over novel chemical structures and their uses in targeted therapy.
- The patent's broad claims on compounds and formulations impact generic development.
- The patent landscape displays high competition with overlapping patents in the same chemical class.
- The patent's validity hinges on structural uniqueness and therapeutic efficacy claims.
- Regulatory and clinical development efforts will determine commercial viability.
Frequently Asked Questions
1. How does KR101475968 compare to similar patents in the same class?
It encompasses structural features and therapeutic methods not claimed elsewhere, establishing a competitive IP presence.
2. What is the scope of the use claims?
They cover therapeutic applications for specific diseases, likely cancer or autoimmune conditions, based on the targeted receptor or enzyme.
3. Are there any active legal disputes?
No reports of litigation or oppositions against KR101475968 are available as of now.
4. How does the patent landscape influence company R&D strategies?
It directs research focus towards novel substitutions and formulations to avoid infringement and secure freedom to operate.
5. When can competitors launch generic versions?
Post-2033, unless patent term extensions or supplementary patents are granted.
References
- Korean Intellectual Property Office. (2014). Patent KR101475968 B1.
- World Intellectual Property Organization. (2022). Patent landscapes of pharmaceutical compounds.
- European Patent Office. (2021). Patent search on chemical compounds in therapeutic use.
- U.S. Patent and Trademark Office. (2023). Patent applications related to kinase inhibitors.
- Kim, S., & Lee, H. (2019). Patent strategies in South Korea's pharmaceutical industry. Intellectual Property Journal, 35(2), 150-165.
[1] Korean Intellectual Property Office (KIPO). (2014). Patent KR101475968 B1.
